SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Directorate Change

4 Feb 2025 07:00

RNS Number : 7141V
Forterra plc
04 February 2025
 

4 February 2025

 

Forterra plc

 

Directorate Change

 

Appointment of Chair

 

Forterra plc ("Forterra" or "the Company"), a leading UK manufacturer of essential clay and concrete building products, is pleased to announce the appointment of Nigel Lingwood as Chair Designate effective from 1 April 2025.

 

Pursuant to the Corporate Governance Code rules regarding independence, Justin Atkinson will step down as Chair and retire from the Board following the conclusion of the Company's Annual General Meeting (AGM) on 20 May 2025. Justin joined Forterra's Board as a non-executive Director in April 2016 and was appointed as Chair in May 2019.

Nigel will succeed Justin as Chair following the conclusion of the Company's AGM.

 

Nigel is an experienced FTSE 250 chair, and former Group Finance Director of Diploma PLC where he spent 19 years overseeing substantial business growth. He is currently Chair of Volution Group plc, a leading supplier of ventilation products to the new build and residential construction markets in the UK, Continental Europe and Australasia. Nigel is also Senior Independent Director at Dialight plc, a global leader in industrial LED lighting technology and solutions. 

 

 Justin Atkinson said:

 

"It has been a pleasure to be on the Forterra Board since its IPO in 2016 and a privilege to have been Chair over the last six years. I look forward to working with Nigel to ensure a smooth transition when he is appointed in April."

 

Commenting on his appointment, Nigel Lingwood said:

 

"I am delighted to be joining Forterra at this juncture and enthused by the opportunity ahead. Forterra is a quality business with strong market presence, and I am looking forward to working with the Board, Neil and the wider team to deliver sustainable growth that will drive value for shareholders."

 

Neil Ash, Chief Executive, said:

 

"I would like to thank Justin for his dedication during his tenure as Chair. His strategic direction and leadership principles have been instrumental in shaping Forterra into the fantastic business it is today. I look forward to working with Nigel as our new Chair, and I'm confident his experience will help drive Forterra's continued success."

 

There are no other items requiring disclosure under paragraph 9.6.13 of the Listing Rules.

 

 

Enquiries:

 

 

 

Forterra plc

01604 707 600

Frances Tock (Company Secretary)

 

 

FTI Consulting

Richard Mountain / Nick Hasell 

020 3727 1340

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATJMATMTMMBFA
Date   Source Headline
20th Jan 20267:00 amRNSEmployee Benefit Trust Share Purchase
7th Jan 20269:39 amRNSEmployee Benefit Trust Share Purchase
2nd Dec 20259:22 amRNSEmployee Benefit Trust Share Purchase
24th Nov 20259:03 amRNSHolding(s) in Company
20th Nov 20259:13 amRNSHolding(s) in Company
18th Nov 20255:03 pmRNSEmployee Benefit Trust Share Purchase
11th Nov 20257:00 amRNSTrading Update
4th Nov 20254:34 pmRNSEmployee Benefit Trust Share Purchase
24th Oct 20251:36 pmRNSHolding(s) in Company
23rd Oct 20251:21 pmRNSDirector/PDMR Shareholding
17th Oct 20259:58 amRNSEmployee Benefit Trust Share Purchase
14th Oct 20259:06 amRNSHolding(s) in Company
13th Oct 202510:15 amRNSEmployee Benefit Trust Share Purchase
2nd Oct 20252:54 pmRNSGrant of Options under 2025 SAYE Scheme
11th Aug 20251:15 pmRNSHolding(s) in Company
29th Jul 20257:38 amRNS-RProgressive publishes new research
29th Jul 20257:00 amRNSSix months ended 30 June 2025
23rd Jul 202510:05 amRNSHolding(s) in Company
19th Jun 20257:05 amRNSDirector Declaration
20th May 20251:47 pmRNSAnnual General Meeting 2025 Results
20th May 20257:43 amRNS-RProgressive publishes new research
20th May 20257:00 amRNSAGM Trading Update
13th May 202510:36 amRNSHolding(s) in Company
11th Apr 20259:18 amRNSDirector / PCA Shareholdings
2nd Apr 20252:22 pmRNSDirector/PDMR Shareholding
26th Mar 20255:53 pmRNSAnnual Report & Accounts 2024 & Notice of AGM 2025
25th Mar 20251:47 pmRNSDirector/PDMR Shareholding
20th Mar 20252:44 pmRNSHolding(s) in Company
20th Mar 20257:00 amRNSGrant under Performance Share Plan
20th Mar 20257:00 amRNSGrant under Deferred Annual Bonus Plan
18th Mar 20252:23 pmRNSHolding(s) in Company
12th Mar 20258:14 amRNS-RProgressive publishes new research
12th Mar 20257:00 amRNSFull Year Results
6th Mar 20257:00 amRNSAppointment of Independent Non-Executive Director
27th Feb 20253:35 pmRNSHolding(s) in Company
26th Feb 20252:50 pmRNSHolding(s) in Company
4th Feb 20257:00 amRNSDirectorate Change
23rd Jan 20257:00 amRNSFull Year 2024 Trading Update
6th Jan 20259:23 amRNSHolding(s) in Company
2nd Jan 202511:38 amRNSDirector/PDMR Shareholding
11th Nov 20247:00 amRNSTrading update to the end of the October
4th Nov 202410:24 amRNSHolding(s) in Company
30th Oct 20244:54 pmRNSHolding(s) in Company
28th Oct 202411:51 amRNSHolding(s) in Company
2nd Oct 20245:35 pmRNSGrant of Options under 2024 SAYE Scheme
11th Sep 20247:00 amRNSDirectorate Change
5th Sep 202411:49 amRNSHolding(s) in Company
2nd Sep 20249:59 amRNSHolding(s) in Company
12th Aug 20243:03 pmRNSHolding(s) in Company
30th Jul 20247:00 amRNSSix months ended 30 June 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.